|
by Newman-Toker, David E.
Published 2022
Published 2022
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Whitlock, Evelyn P., Williams, Selvi, Burda, Brittany U., Feightner, Alisha
Published 2015
Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Whitlock, Evelyn P., Williams, Selvi, Burda, Brittany U., Feightner, Alisha
Published 2015
Published 2015
Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|
by Moher, David
Published 2010
Published 2010
Agency for Healthcare Research and Quality, U.S. Dept. of Health and Human Services
|
by Marchand, Dave K., Farrah, Kelly
Published 2019
“..., bound to fibrin clots, to plasmin resulting in the degradation of the clot. However, a re-infarction...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Marchand, Dave K., Farrah, Kelly
Published 2019
“..., bound to fibrin clots, to plasmin resulting in the degradation of the clot. However, a re-infarction...”Published 2019
Canadian Agency for Drugs and Technologies in Health